The firm said it is helping customers convert from SNP genotyping arrays to an NGS workflow, which may allow it to access the ag-bio and direct-to-consumer markets.
New instrument releases at this week's meeting reflected proteomics' increased emphasis on throughput and the continuing spread of ion mobility technology.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
